Back
Rocket Pharmaceuticals Vs. Ligand Pharmaceuticals Industry Stock Comparison
Buy
58
RCKT
Rocket Pharmaceuticals
Last Price:
23.46
Seasonality Move:
12.54%
Sell
40
LGND
Ligand Pharmaceuticals
Last Price:
73.90
Seasonality Move:
4.37%
Buy
58
Rocket Pharmaceuticals (RCKT)
is a Buy
Is Rocket Pharmaceuticals a Buy, Sell or Hold?
- The current Rocket Pharmaceuticals [RCKT] share price is $23.47. The Score for RCKT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- RCKT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Ligand Pharmaceuticals (LGND)
is a Sell
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $73.90. The Score for LGND is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- LGND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals's stock price today?
-
The Rocket Pharmaceuticals share price today is $23.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $73.90
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.
RCKT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.97 | Sell |
Relative Strength Index (14 RSI): | 46.12 | Sell |
Chaikin Money Flow: | -324180 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.59 - 25.19) | Sell |
Bollinger Bands (100): | (24.95 - 29.67) | Sell |
LGND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1 | Sell |
Relative Strength Index (14 RSI): | 51.28 | Buy |
Chaikin Money Flow: | 93918 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (70.65 - 79.33) | Sell |
Bollinger Bands (100): | (69.47 - 77.33) | Buy |
RCKT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.49 | Buy |
20-day SMA: | 23.47 | Buy |
50-day SMA: | 25.92 | Sell |
200-day SMA: | 23.15 | Buy |
8-day EMA: | 22.79 | Buy |
20-day EMA: | 23.54 | Sell |
50-day EMA: | 25.1 | Sell |
200-day EMA: | 24.11 | Sell |
LGND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 71.27 | Buy |
20-day SMA: | 74.86 | Sell |
50-day SMA: | 74.61 | Sell |
200-day SMA: | 67.02 | Buy |
8-day EMA: | 72.11 | Buy |
20-day EMA: | 73.16 | Buy |
50-day EMA: | 73.62 | Buy |
200-day EMA: | 70.89 | Buy |
Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.26 per share, an increase this year of $0.38 per share, and an increase next year of $0.83 per share.
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.59 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.91 per share, and an increase next year of $1.16 per share.
Rocket Pharmaceuticals Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ligand Pharmaceuticals Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |